Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics
暂无分享,去创建一个
[1] E. de Vries,et al. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe. , 2004, European journal of cancer.
[2] F Berrino,et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] C. Luke,et al. A critical analysis of reasons for improved survival from invasive cutaneous melanoma , 2003, Cancer Causes & Control.
[4] F. Bray,et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia , 2003, International journal of cancer.
[5] P. Carli,et al. Unexpected reduction of mortality rates from melanoma in males living in central Italy. , 2003, European journal of cancer.
[6] P. Carli,et al. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. , 2003, European journal of dermatology : EJD.
[7] M. Nicolson,et al. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study , 2002, The Lancet.
[8] B. Kulle,et al. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy. , 2002, European journal of cancer.
[9] U. Ringborg,et al. Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994 , 2002, Acta oncologica.
[10] K. Jöckel,et al. Skin melanoma in Saarland: incidence, survival and mortality 1970–1996 , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[11] D. Roberts,et al. Malignant melanoma in South Wales: changing trends in presentation (1986–98) , 2001, Clinical and experimental dermatology.
[12] S. Moss,et al. Evaluation of primary prevention initiatives for skin cancer: a review from a U.K. perspective , 2000, The British journal of dermatology.
[13] M. Coleman,et al. Completeness of cancer registration: a new method for routine use , 2000, British Journal of Cancer.
[14] D. Lipsker,et al. Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. , 1999, Archives of dermatology.
[15] J. Naeyaert,et al. Under-registration of melanoma in Belgium: an analysis. , 1999, Melanoma research.
[16] Coebergh,et al. Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980–95 , 1999, The British journal of dermatology.
[17] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.
[18] J. Melia,et al. Problems with registration of cutaneous malignant melanoma in England. , 1995, British Journal of Cancer.
[19] R. MacKie,et al. Cutaneous malignant melanoma, Scotland, 1979-89 , 1992, The Lancet.
[20] C. Patterson,et al. Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis. , 1991, British Journal of Cancer.
[21] E. D. Vriesa,et al. Lower incidence rates but thicker melanomas in Eastern Europe before 1992 : a comparison with Western Europe , 2004 .
[22] J. Hunter,et al. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. , 1992, Lancet.